Home
About
Overview
Sharing Data
ORCID
Help
History (41)
Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies.
Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration.
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research Network.
Port-Site Metastasis in Gynecological Malignancies.
See All 41 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Port-Site Metastasis in Gynecological Malignancies.
Benabou K, Khadraoui W, Khader T, Hui P, Fernandez R, Azodi M, Menderes G. Port-Site Metastasis in Gynecological Malignancies. JSLS. 2021 Jan-Mar; 25(1).
View in:
PubMed
subject areas
Abdominal Neoplasms
Abdominal Wall
Adenocarcinoma
Adult
Female
Humans
Hysterectomy
Laparoscopy
Neoplasm Seeding
Robotic Surgical Procedures
Uterine Cervical Neoplasms
authors with profiles
Kelly Benabou MD, MS